Volume 49; Issue 2

Main
Antiviral Research
Volume 49; Issue 2

Antiviral Research

Volume 49; Issue 2

1

Genetic risks of antiviral nucleoside analogues – a survey

Peter Wutzler, Rudolf Thust

Journal:

Antiviral Research

Year:

2001

Language:

english

File:

PDF, 188 KB

english, 2001

2

Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial

Pietro Andreone, Sirio Fiorino, Carmela Cursaro, Annagiulia Gramenzi, Marzia Margotti, Loriana Di Giammarino, Maurizio Biselli, Rita Miniero, Giovanni Gasbarrini, Mauro Bernardi

Journal:

Antiviral Research

Year:

2001

Language:

english

File:

PDF, 92 KB

english, 2001

3

A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection

S.A Mohamedi, A.W Heath, R Jennings

Journal:

Antiviral Research

Year:

2001

Language:

english

File:

PDF, 373 KB

english, 2001

4

Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374

Lamia Sharmeen, Thomas McQuade, Andrea Heldsinger, Rocco Gogliotti, John Domagala, Stephen Gracheck

Journal:

Antiviral Research

Year:

2001

Language:

english

File:

PDF, 275 KB

english, 2001

5

Anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)-cycloprop-1′-yl]methyl]guanine (A-5021) in vitro and in vivo

Johan Neyts, Lieve Naesens, Chunxiao Ying, Leen De Bolle, Erik De Clercq

Journal:

Antiviral Research

Year:

2001

Language:

english

File:

PDF, 84 KB

english, 2001

6

The anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil

Johan Neyts, Erik De Clercq

Journal:

Antiviral Research

Year:

2001

Language:

english

File:

PDF, 175 KB

english, 2001